This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.
Get full access to this article
View all access options for this article.
References
1.
BarrJFraserGLPuntilloK. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med.2013; 41:263–306.
2.
OhtaTMuraoKMiyakeKTakemotoK.Melatonin receptor agonists for treating delirium in elderly patients with acute stroke. J Stroke Cerebrovasc Dis.In press.
3.
KimuraRMoriKKumazakiHYanagidaMTaguchiSMatsunagaH.Treatment of delirium with ramelton: initial experience in three patients. Gen Hosp Psychiatry.2011;33:407–409.
4.
FuruyaMMiyaokaTYasudaH. Marked improvement in delirium with ramelton: five case reports. Psychogeriatrics.2012; 12:259–262.
